Department of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China ; Clinical Center for Human Genomic Research, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
PLoS One. 2013 Dec 19;8(12):e82872. doi: 10.1371/journal.pone.0082872. eCollection 2013.
The transcription factor Sp1 is implicated in the activation of G0/G1 phase genes. Modulation of Sp1 transcription activities may affect G1-S checkpoint, resulting in changes in cell proliferation. In this study, our results demonstrated that activated poly(ADP-ribose) polymerase 1 (PARP-1) promoted cell proliferation by inhibiting Sp1 signaling pathway. Cell proliferation and cell cycle assays demonstrated that PARP inhibitors or PARP-1 siRNA treatment significantly inhibited proliferation of hepatoma cells and induced G0/G1 cell cycle arrest in hepatoma cells, while overexpression of PARP-1 or PARP-1 activator treatment promoted cell cycle progression. Simultaneously, inhibition of PARP-1 enhanced the expression of Sp1-mediated checkpoint proteins, such as p21 and p27. In this study, we also showed that Sp1 was poly(ADP-ribosyl)ated by PARP-1 in hepatoma cells. Poly(ADP-ribosyl)ation suppressed Sp1 mediated transcription through preventing Sp1 binding to the Sp1 response element present in the promoters of target genes. Taken together, these data indicated that PARP-1 inhibition attenuated the poly(ADP-ribosyl)ation of Sp1 and significantly increased the expression of Sp1 target genes, resulting in G0/G1 cell cycle arrest and the decreased proliferative ability of the hepatoma cells.
转录因子 Sp1 被认为参与了 G0/G1 期基因的激活。Sp1 转录活性的调节可能会影响 G1-S 检查点,导致细胞增殖发生变化。在这项研究中,我们的结果表明,激活的多聚(ADP-核糖)聚合酶 1(PARP-1)通过抑制 Sp1 信号通路促进细胞增殖。细胞增殖和细胞周期分析表明,PARP 抑制剂或 PARP-1 siRNA 处理显著抑制肝癌细胞的增殖,并诱导肝癌细胞中的 G0/G1 细胞周期停滞,而过表达 PARP-1 或 PARP-1 激活剂处理则促进细胞周期进程。同时,抑制 PARP-1 增强了 Sp1 介导的检查点蛋白的表达,如 p21 和 p27。在这项研究中,我们还表明 PARP-1 在肝癌细胞中对 Sp1 进行多聚(ADP-核糖)化。多聚(ADP-核糖)化通过阻止 Sp1 结合靶基因启动子中存在的 Sp1 反应元件,从而抑制 Sp1 介导的转录。总之,这些数据表明,PARP-1 抑制减弱了 Sp1 的多聚(ADP-核糖)化,并显著增加了 Sp1 靶基因的表达,导致 G0/G1 细胞周期停滞和肝癌细胞增殖能力降低。